Pittcon Now Accepting Grant Proposals for 2014
News Jul 15, 2013
The Pittsburgh Conference and its sponsoring societies, the Spectroscopy Society of Pittsburgh (SSP) and the Society for Analytical Chemists of Pittsburgh (SACP), are now accepting proposals for the 2014 Pittsburgh Conference Memorial National College Grants (PCMNCG) Award Program. Qualifying organizations are invited to consider applying for one of this year's awards. The deadline for receipt of completed applications and proposals is October 1, 2013.
Click here to get information about the award, the application form, a description of the eligibility criteria, and a list of previous award recipients.
Awards will be announced during the month of January 2014. Schools chosen will join the list of more than 300 institutions honored since the inception of this program in 1974. In 1974, two grants of $1,000 each were given. This year, the maximum funding available for each grant is $10,000, and there will be at least 10 of these awards. Each proposal will be reviewed by an evaluation committee comprised of members of the SSP and the SACP. Last year, there were 49 proposals from small colleges and universities who met the requirements.
The Pittsburgh Conference Memorial National College Grants Program, originally established in memory of R. K. Scott, 1955 president of the Pittsburgh Conference, serves as a memorial to deceased members of the Pittsburgh Conference Committee by promoting excellence in science education. Through the program, small colleges can enhance their science curricula through grants to purchase equipment and course materials.
Children With Congenital Zika Virus Infection Face Serious Challenges as They AgeNews
The report from the CDC is the first to describe the health and developmental effects of congenital Zika virus infection in children with microcephaly through 2 years of age.READ MORE
British Pharmacological Society’s Drug Discovery of the Year 2018 AnnouncedNews
A new medicine used to treat an ultra-rare inherited disorder which leaves babies without a fully functioning immune system has been named the British Pharmacological Society’s Drug Discovery of the Year 2018.READ MORE